Prospective study of a pirarubicin, intermediate-dose cytarabine, and etoposide regimen in children with Down syndrome and acute myeloid leukemia: the Japanese Childhood AML Cooperative Study Group - Kudo, K; Kojima, S; Tabuchi, K (J Clin Oncol, 2007)